StockData
Vicapsys Life Sciences, Inc. logo

Vicapsys Life Sciences, Inc. (VICP) stock

VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)

Close on Oct 19, 2026Market cap $13.73MP/E –Yield –

Vicapsys Life Sciences cash

Cash and short-term investments held at the end of each period.

Vicapsys Life Sciences's cash was $89.57K at Sep 30, 2024. For fiscal 2023 it was $9.42K, down 33.2% from the year before. The highest annual figure on record is $264.17K in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2023Dec 31, 2023$9.42K-33.2%
FY2022Dec 31, 2022$14.10K-93.5%
FY2021Dec 31, 2021$217.30K+17023.3%
FY2020Dec 31, 2020$1.27K-99.5%
FY2019Dec 31, 2019$264.17K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2024Sep 30, 2024$89.57K+2063.5%
Q4 FY2023Dec 31, 2023$9.42K-33.2%
Q3 FY2023Sep 30, 2023$53.53K+104.2%
Q2 FY2023Jun 30, 2023$231.28K+1237.7%
Q1 FY2023Mar 31, 2023$4.14K-95.9%
Q4 FY2022Dec 31, 2022$14.10K-93.5%
Q3 FY2022Sep 30, 2022$26.21K-84.2%
Q2 FY2022Jun 30, 2022$17.29K-89.9%
Q1 FY2022Mar 31, 2022$101.32K+232.6%
Q4 FY2021Dec 31, 2021$217.30K+17023.3%
Q3 FY2021Sep 30, 2021$165.55K+9909.0%
Q2 FY2021Jun 30, 2021$170.62K+3322.1%
Q1 FY2021Mar 31, 2021$30.46K-1.6%
Q4 FY2020Dec 31, 2020$1.27K-99.5%
Q3 FY2020Sep 30, 2020$1.65K–
Q2 FY2020Jun 30, 2020$4.99K–
Q1 FY2020Mar 31, 2020$30.95K–
Q4 FY2019Dec 31, 2019$264.17K–

More Vicapsys Life Sciences figures

See a number that looks wrong?